Population
Patients with advanced end-stage heart failure
Design
Review
Key result
Left ventricular assist devices (LVADs) provide a valuable bridge or destination therapy for end-stage heart failure, with next-generation devices potentially improving outcomes in less sick patients.
Authors
Loading...
May guide LVAD selection in advanced HF; leaves open expansion to less sick patients pending prospective trials.
This review highlights the evolving role of LVADs in end-stage heart failure, emphasizing the potential of next-generation devices to expand indications to less sick patients.
Sunagawa et al. (2017) conducted a review in Advanced end-stage heart failure. Left ventricular assist devices (LVADs) was evaluated. Left ventricular assist devices (LVADs) provide a valuable bridge or destination therapy for end-stage heart failure, with next-generation devices potentially improving outcomes in less sick patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: